藥用明膠市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、來源、功能、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球藥用明膠市場價值為 18.9 億美元，預計到 2030 年將達到 26.1 億美元，複合年成長率為 5.51%。藥用明膠是一種重要的賦形劑，因其生物相容性且能夠滿足嚴格的安全性和純度標準，廣泛用於膠囊、藥片和止血劑等藥物製劑中。藥用明膠主要來自動物膠原蛋白，經過嚴格的加工，包括滅菌和淨化，以確保其不含病原體、過敏原和有害物質。它在增強藥物穩定性、生物利用度和患者依從性方面的一致表現使其成為各種治療應用中不可或缺的一部分。地區偏好和監管指南通常決定明膠的來源—無論是牛、豬、魚或家禽。口服劑型的需求不斷成長，加上製藥製造技術的進步，持續推動全球市場擴張。

關鍵市場促進因素

製藥業蓬勃發展

主要市場挑戰

原物料供應和價格波動

主要市場趨勢

轉向植物性替代品

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球藥用明膠市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按類型（A型、B型）
  • 依來源（豬、牛皮、牛骨、魚、家禽）
  • 依功能（穩定、增稠、膠凝、其他）
  • 按最終用戶（硬膠囊、軟膠囊、片劑、可吸收止血劑、其他）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美藥用明膠市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲藥用明膠市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太藥用明膠市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲藥用明膠市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲藥用明膠市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Gelita AG
• Trobas Pharmaceutical gelatine BV
• Rousselot SAS
• Gelatines Weishardt SAS
• Sterling Biotec Ltd.
• Catalent, Inc
• Nitta Pharmaceutical Gelatin India Limited
• Aspire Pharmaceuticals
• Gelco International
• Lapi Gelatine Spa

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Pharmaceutical Gelatin Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.61 billion by 2030, registering a CAGR of 5.51%. Pharmaceutical gelatin is a critical excipient widely used in drug formulations such as capsules, tablets, and hemostats due to its biocompatibility and ability to meet stringent safety and purity standards. Derived primarily from animal collagen, pharmaceutical gelatin undergoes rigorous processing, including sterilization and purification, to ensure it is free from pathogens, allergens, and harmful substances. Its consistent performance in enhancing drug stability, bioavailability, and patient compliance makes it indispensable across various therapeutic applications. Regional preferences and regulatory guidelines often dictate the source of gelatin-whether bovine, porcine, fish, or poultry. The growing demand for oral dosage forms, coupled with technological advances in pharmaceutical manufacturing, continues to propel market expansion globally.

Key Market Drivers

Growing Pharmaceutical Industry

The expanding pharmaceutical sector is a primary driver of the pharmaceutical gelatin market, with increasing demand for effective and patient-friendly dosage forms such as capsules. Gelatin plays a vital role in improving drug solubility, enabling controlled drug release, and enhancing the overall stability of active pharmaceutical ingredients (APIs). Regulatory bodies like the FDA and EMA recognize gelatin as a safe and effective excipient when manufactured under strict quality controls and Good Manufacturing Practices (GMP). This endorsement strengthens its widespread use in both conventional and advanced drug delivery systems. As pharmaceutical innovation continues to grow, particularly in personalized medicine and complex therapies, gelatin's functional versatility is expected to further solidify its market position.

Key Market Challenges

Raw Material Supply and Price Volatility

The pharmaceutical gelatin market faces notable challenges due to the reliance on animal-derived raw materials such as bovine and porcine collagen. Factors like disease outbreaks (e.g., African swine fever), climate events, and fluctuating livestock populations can disrupt supply chains and elevate production costs. Environmental concerns, ethical considerations, and rising interest in alternative materials also add complexity to sourcing decisions. Additionally, raw material costs are sensitive to variables such as feed prices, transportation, and currency fluctuations, leading to inconsistent pricing. Meeting stringent regulatory requirements for pharmaceutical-grade gelatin adds further layers of cost and operational effort. These dynamics collectively pose risks to production stability and profitability, particularly for manufacturers operating in price-sensitive markets.

Key Market Trends

Shift Towards Plant-Based Alternatives

The rising demand for sustainable, cruelty-free, and allergen-friendly products is driving interest in plant-based alternatives to animal-derived pharmaceutical gelatin. These alternatives cater to growing vegan and vegetarian populations and meet religious or cultural dietary restrictions. They also present a more environmentally sustainable option, often requiring fewer natural resources and generating lower greenhouse gas emissions. Recent advancements in food and material science have enabled the development of plant-based gelling agents that mimic the functional properties of traditional gelatin. As pharmaceutical companies seek to diversify their excipient sources, plant-based gelatin substitutes are gaining attention for their potential to meet both functional and ethical criteria. However, achieving comparable performance and regulatory approval remains a focus of ongoing innovation.

Key Market Players

• Gelita AG
• Trobas Pharmaceutical gelatine B.V
• Rousselot SAS
• Gelatines Weishardt SAS
• Sterling Biotec Ltd.
• Catalent, Inc
• Nitta Pharmaceutical Gelatin India Limited
• Aspire Pharmaceuticals
• Gelco International
• Lapi Gelatine S.p.a

Report Scope:

In this report, the Global Pharmaceutical Gelatin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Gelatin Market, By Type:

• Type A
• Type B

Pharmaceutical Gelatin Market, By Source:

• Porcine
• Bovine Skin
• Bovine Bone
• Fish
• Poultry

Pharmaceutical Gelatin Market, By Function:

• Stabilizing
• Thickening
• Gelling
• Others

Pharmaceutical Gelatin Market, By End User:

• Hard Capsule
• Soft Capsule
• Tablet
• Absorbable Hemostat
• Others

Pharmaceutical Gelatin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Pharmaceutical Gelatin Market.

Available Customizations:

Global Pharmaceutical Gelatin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Pharmaceutical Gelatin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Type A, Type B)
  • 5.2.2. By Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry)
  • 5.2.3. By Function (Stabilizing, Thickening, Gelling, Others)
  • 5.2.4. By End User (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Pharmaceutical Gelatin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Source
  • 6.2.3. By Function
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Gelatin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Source
      • 6.3.1.2.3. By Function
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Pharmaceutical Gelatin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Source
      • 6.3.2.2.3. By Function
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Pharmaceutical Gelatin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Source
      • 6.3.3.2.3. By Function
      • 6.3.3.2.4. By End User

7. Europe Pharmaceutical Gelatin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Source
  • 7.2.3. By Function
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Pharmaceutical Gelatin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Source
      • 7.3.1.2.3. By Function
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Pharmaceutical Gelatin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Source
      • 7.3.2.2.3. By Function
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Pharmaceutical Gelatin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Source
      • 7.3.3.2.3. By Function
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Pharmaceutical Gelatin Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Source
      • 7.3.4.2.3. By Function
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Pharmaceutical Gelatin Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Source
      • 7.3.5.2.3. By Function
      • 7.3.5.2.4. By End User

8. Asia-Pacific Pharmaceutical Gelatin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Source
  • 8.2.3. By Function
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Gelatin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Source
      • 8.3.1.2.3. By Function
      • 8.3.1.2.4. By End User
  • 8.3.2. India Pharmaceutical Gelatin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Source
      • 8.3.2.2.3. By Function
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Pharmaceutical Gelatin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Source
      • 8.3.3.2.3. By Function
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Pharmaceutical Gelatin Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Source
      • 8.3.4.2.3. By Function
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Pharmaceutical Gelatin Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Source
      • 8.3.5.2.3. By Function
      • 8.3.5.2.4. By End User

9. South America Pharmaceutical Gelatin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Source
  • 9.2.3. By Function
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pharmaceutical Gelatin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Source
      • 9.3.1.2.3. By Function
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Pharmaceutical Gelatin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Source
      • 9.3.2.2.3. By Function
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Pharmaceutical Gelatin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Source
      • 9.3.3.2.3. By Function
      • 9.3.3.2.4. By End User

10. Middle East and Africa Pharmaceutical Gelatin Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Source
  • 10.2.3. By Function
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pharmaceutical Gelatin Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Source
      • 10.3.1.2.3. By Function
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Pharmaceutical Gelatin Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Source
      • 10.3.2.2.3. By Function
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Pharmaceutical Gelatin Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Source
      • 10.3.3.2.3. By Function
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Gelita AG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Trobas Pharmaceutical gelatine B.V
• 14.3. Rousselot SAS
• 14.4. Gelatines Weishardt SAS
• 14.5. Sterling Biotec Ltd.
• 14.6. Catalent, Inc
• 14.7. Nitta Pharmaceutical Gelatin India Limited
• 14.8. Aspire Pharmaceuticals
• 14.9. Gelco International
• 14.10. Lapi Gelatine S.p.a

15. Strategic Recommendations

16. About Us & Disclaimer